|Articles|June 15, 2015

BioPharm International

  • BioPharm International-06-15-2015
  • Volume 2015 eBook
  • Issue 1

Taking a “Development-by-Design” Approach to Cell Therapies

Author(s)Agnes Shanley

Whether outsourcing or developing cell therapies in-house, success demands a focus on quality, cost of goods, and sustainability from the start.

Cell therapies, both autologous and allogeneic, have come a long way in just a few years. Failures, often in clinical stages, have been traced to problems with manufacturing and failure to understand process requirements earlier in the development process.

 

Download

BioPharm International’s 2015 Outsourcing Resources eBook

.

 

 

 

 

Articles in this issue

over 10 years ago

QRM Tools for Contract Biomanufacturing

over 10 years ago

Fill/Finish Trends

over 10 years ago

Biopharma Advances Demand Specialized Expertise

over 10 years ago

Protecting Intellectual Property in Engagements with CMOs

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Related Content